These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6151352)

  • 21. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain.
    Gresíková M; Sekeyová M; Marcinka K; Ciampor F
    Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral immunity and correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis virus in children.
    Venturi G; Mel R; Marchi A; Mancuso S; Russino F; Pra GD; Papa N; Bertiato G; Fiorentini C; Ciufolini MG
    J Virol Methods; 2006 Jun; 134(1-2):136-9. PubMed ID: 16458368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals].
    Korovina GI; Titova TS; Churnosov EV
    Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183
    [No Abstract]   [Full Text] [Related]  

  • 25. Peroral immunization of adult white mice with the Skalica strain from the tick-borne encephalitis virus complex.
    Elecková E; Gresíková M
    Acta Virol; 1992 Oct; 36(5):466-72. PubMed ID: 1364023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination.
    Remoli ME; Marchi A; Fortuna C; Benedetti E; Minelli G; Fiorentini C; Mel R; Venturi G; Ciufolini MG
    Pathog Dis; 2015 Mar; 73(2):1-3. PubMed ID: 25722483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.
    Weinberger B; Keller M; Fischer KH; Stiasny K; Neuner C; Heinz FX; Grubeck-Loebenstein B
    Vaccine; 2010 Apr; 28(20):3511-5. PubMed ID: 20332047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
    Pazdiora P; Januska J
    Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished response to tick-borne encephalitis vaccination in thymectomized children.
    Prelog M; Wilk C; Keller M; Karall T; Orth D; Geiger R; Walder G; Laufer G; Cottogni M; Zimmerhackl Lothar B; Stein J; Grubeck-Loebenstein B; Wuerzner R
    Vaccine; 2008 Jan; 26(5):595-600. PubMed ID: 18178293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of serum levels of tick-borne encephalitis (TBE) virus antibodies after administration of FSME inject vaccine].
    Pancewicz SA; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2002; 56 Suppl 1():116-21. PubMed ID: 12194225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional activity of specific antibodies in patients vaccinated against tick-borne encephalitis in relation to different virus strains].
    Leonova GN; Pavlenko EV
    Vopr Virusol; 2010; 55(3):33-7. PubMed ID: 20608079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of antibodies after immunization with the FSME-Immun vaccine].
    Pazdiora P; Januska J; Kubátová A
    Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):110-4. PubMed ID: 11040492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological status of people inoculated with various types of inactivated vaccine against tick-borne encephalitis].
    Pervikov IuV; El'bert LB; Krutianskaia GL; Belotskiĭ SM; Krasil'nikov IV
    Vopr Virusol; 1982; 27(6):696-701. PubMed ID: 7157778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
    Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination against tick-borne encephalitis in the Central Slovakia Region using a Soviet vaccine].
    Palanová A; Gresíková M; Sekeyová M; Pötheová A; Galvánek I; Januska J
    Cesk Epidemiol Mikrobiol Imunol; 1992 Jun; 41(2):69-77. PubMed ID: 1387048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vesicular stomatitis virus pseudotype with neutralization antigen of tick-borne encephalitis virus.
    Dragúnová J; Greśíková M
    Acta Virol; 1986 Jul; 30(4):346-8. PubMed ID: 2876617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.
    Schuller E; Klade CS; Heinz FX; Kollaritsch H; Rendi-Wagner P; Jilma B; Tauber E
    Vaccine; 2008 Nov; 26(48):6151-6. PubMed ID: 18804132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination.
    Paulke-Korinek M; Kundi M; Laaber B; Brodtraeger N; Seidl-Friedrich C; Wiedermann U; Kollaritsch H
    Vaccine; 2013 Feb; 31(9):1293-7. PubMed ID: 23306371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.